The novel dithiocarbamate, DpdtC suppresses HER2-overexpressed cancer cells by up-regulating NDRG1 via inactivation of HER2-ERK 1/2 signaling
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The novel dithiocarbamate, DpdtC suppresses HER2-overexpressed cancer cells by up-regulating NDRG1 via inactivation of HER2-ERK 1/2 signaling
Authors
Keywords
-
Journal
Scientific Reports
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-02-16
DOI
10.1038/s41598-018-21768-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Interplay of the iron-regulated metastasis suppressor NDRG1 with epidermal growth factor receptor (EGFR) and oncogenic signaling
- (2017) Sharleen V. Menezes et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- The antiproliferative activity of di-2-pyridylketone dithiocarbamate is partly attributed to catalase inhibition: detailing the interaction by spectroscopic methods
- (2017) Cuiping Li et al. Molecular BioSystems
- Targeting EGFR/HER2 heterodimerization with a novel anti-HER2 domain II/III antibody
- (2017) Xiaojie Yu et al. MOLECULAR IMMUNOLOGY
- Calcium release induced by 2-pyridinecarboxaldehyde thiosemicarbazone and its copper complex contributes to tumor cell death
- (2017) Yun Fu et al. ONCOLOGY REPORTS
- Copper Ion Attenuated the Antiproliferative Activity of Di-2-pyridylhydrazone Dithiocarbamate Derivative; However, There Was a Lack of Correlation between ROS Generation and Antiproliferative Activity
- (2016) Tingting Wang et al. MOLECULES
- The Metastasis Suppressor, N-MYC Downstream-regulated Gene-1 (NDRG1), Down-regulates the ErbB Family of Receptors to Inhibit Downstream Oncogenic Signaling Pathways
- (2015) Zaklina Kovacevic et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Combining trastuzumab and cetuximab combats trastuzumab-resistant gastric cancer by effective inhibition of EGFR/ErbB2 heterodimerization and signaling
- (2014) Lei Zheng et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Dp44mT targets the AKT, TGF-β and ERK pathways via the metastasis suppressor NDRG1 in normal prostate epithelial cells and prostate cancer cells
- (2013) K M Dixon et al. BRITISH JOURNAL OF CANCER
- Bispecific Antibody to ErbB2 Overcomes Trastuzumab Resistance through Comprehensive Blockade of ErbB2 Heterodimerization
- (2013) B. Li et al. CANCER RESEARCH
- Metastasis suppressor, NDRG1, mediates its activity through signaling pathways and molecular motors
- (2013) J. Sun et al. CARCINOGENESIS
- N-myc Downstream Regulated 1 (NDRG1) Is Regulated by Eukaryotic Initiation Factor 3a (eIF3a) during Cellular Stress Caused by Iron Depletion
- (2013) Darius J. R. Lane et al. PLoS One
- The Iron-Regulated Metastasis Suppressor NDRG1 Targets NEDD4L, PTEN, and SMAD4 and Inhibits the PI3K and Ras Signaling Pathways
- (2012) Zaklina Kovacevic et al. ANTIOXIDANTS & REDOX SIGNALING
- Novel Chelators for Cancer Treatment: Where Are We Now?
- (2012) Angelica M. Merlot et al. ANTIOXIDANTS & REDOX SIGNALING
- N-myc downstream regulated gene 1 modulates Wnt-β-catenin signalling and pleiotropically suppresses metastasis
- (2012) Wen Liu et al. EMBO Molecular Medicine
- The Iron Chelators Dp44mT and DFO Inhibit TGF-β-induced Epithelial-Mesenchymal Transition via Up-Regulation of N-Myc Downstream-regulated Gene 1 (NDRG1)
- (2012) Zhiqiang Chen et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Dithiocarbamate-based coordination compounds as potent proteasome inhibitors in human cancer cells
- (2012) Daniela Buac et al. MINI-REVIEWS IN MEDICINAL CHEMISTRY
- Novel Thiosemicarbazone Iron Chelators Induce Up-Regulation and Phosphorylation of the Metastasis Suppressor N-myc Down-Stream Regulated Gene 1: A New Strategy for the Treatment of Pancreatic Cancer
- (2011) Z. Kovacevic et al. MOLECULAR PHARMACOLOGY
- A two-tiered mechanism of EGFR inhibition by RALT/MIG6 via kinase suppression and receptor degradation
- (2010) Yuri Frosi et al. JOURNAL OF CELL BIOLOGY
- The oral iron chelator deferasirox represses signaling through the mTOR in myeloid leukemia cells by enhancing expression of REDD1
- (2009) Junko H. Ohyashiki et al. CANCER SCIENCE
- Iron Chelator-Mediated Alterations in Gene Expression: Identification of Novel Iron-Regulated Molecules That Are Molecular Targets of Hypoxia-Inducible Factor-1 and p53
- (2009) F. Saletta et al. MOLECULAR PHARMACOLOGY
- The iron-regulated metastasis suppressor, Ndrg-1: Identification of novel molecular targets
- (2008) Zaklina Kovacevic et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now